Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 727

1.

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH; European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group.

Int J Cancer. 2002 Jan 10;97(2):237-44.

PMID:
11774270
[PubMed - indexed for MEDLINE]
2.

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Mar 16;97(6):433-8.

PMID:
15770007
[PubMed - indexed for MEDLINE]
Free Article
3.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
[PubMed - indexed for MEDLINE]
4.

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Pinsky PF, Blacka A, Kramer BS, Miller A, Prorok PC, Berg C.

Clin Trials. 2010 Aug;7(4):303-11. doi: 10.1177/1740774510374091. Epub 2010 Jun 22.

PMID:
20571134
[PubMed - indexed for MEDLINE]
5.

[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].

Jegu J, Tretarre B, Grosclaude P, Rebillard X, Bataille V, Malavaud B, Iborra F, Salama G, Rischmann P, Villers A.

Prog Urol. 2009 Jul;19(7):487-98. doi: 10.1016/j.purol.2009.03.001. Epub 2009 Apr 28. French.

PMID:
19559380
[PubMed - indexed for MEDLINE]
6.

Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Otto SJ, van der Cruijsen IW, Liem MK, Korfage IJ, Lous JJ, Schröder FH, de Koning HJ.

Int J Cancer. 2003 Jun 20;105(3):394-9.

PMID:
12704675
[PubMed - indexed for MEDLINE]
7.

Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.

Schröder FH, Bangma CH, Roobol MJ.

Eur Urol. 2008 May;53(5):901-8. doi: 10.1016/j.eururo.2008.01.048. Epub 2008 Jan 28.

PMID:
18262712
[PubMed - indexed for MEDLINE]
8.

Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Schröder FH, van der Maas P, Beemsterboer P, Kruger AB, Hoedemaeker R, Rietbergen J, Kranse R.

J Natl Cancer Inst. 1998 Dec 2;90(23):1817-23.

PMID:
9839522
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.

Beemsterboer PM, de Koning HJ, Kranse R, Trienekens PH, van der Maas PJ, Schröder FH.

J Urol. 2000 Oct;164(4):1216-20.

PMID:
10992369
[PubMed - indexed for MEDLINE]
11.

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Project Team.

J Urol. 2005 Mar;173(3):746-50; discussion 750-1.

PMID:
15711261
[PubMed - indexed for MEDLINE]
12.

Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.

Roobol MJ, Grenabo A, Schröder FH, Hugosson J.

J Natl Cancer Inst. 2007 Sep 5;99(17):1296-303. Epub 2007 Aug 28.

PMID:
17728218
[PubMed - indexed for MEDLINE]
Free Article
13.

Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial.

de Koning HJ, Liem MK, Baan CA, Boer R, Schröder FH, Alexander FE; ERSPC.

Int J Cancer. 2002 Mar 10;98(2):268-73.

PMID:
11857418
[PubMed - indexed for MEDLINE]
14.

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.

Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R.

Urology. 2001 Jan;57(1):83-90.

PMID:
11164149
[PubMed - indexed for MEDLINE]
15.

Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Luján M, Páez A, Pascual C, Angulo J, Miravalles E, Berenguer A.

Eur Urol. 2006 Dec;50(6):1234-40; discussion 1239-40. Epub 2006 May 3.

PMID:
16704893
[PubMed - indexed for MEDLINE]
16.

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S.

PMID:
11189684
[PubMed - indexed for MEDLINE]
17.

Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Urol Oncol. 2008 Sep-Oct;26(5):533-41. doi: 10.1016/j.urolonc.2008.03.011.

PMID:
18774469
[PubMed - indexed for MEDLINE]
18.

Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam.

van der Cruijsen-Koeter IW, van der Kwast TH, Schröder FH.

J Natl Cancer Inst. 2003 Oct 1;95(19):1462-6.

PMID:
14519752
[PubMed - indexed for MEDLINE]
Free Article
19.

Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

Wever EM, Draisma G, Heijnsdijk EA, Roobol MJ, Boer R, Otto SJ, de Koning HJ.

J Natl Cancer Inst. 2010 Mar 3;102(5):352-5. doi: 10.1093/jnci/djp533. Epub 2010 Feb 8.

PMID:
20142584
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D.

Urology. 2003 Apr;61(4):754-9.

PMID:
12670560
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk